Skip to main content
RT @DrMiniDey: Delighted to be reporting for @RheumNow at #ACR20!

Here, I review the last year in #infection in #rheuma

Mrinalini Dey DrMiniDey

5 years 11 months ago
Delighted to be reporting for @RheumNow at #ACR20! Here, I review the last year in #infection in #rheumaticdiseases (it’s been a busy one!) and highlight just a few of the abstracts on infections (incl #COVID19), #vaccination and #immunogenicity. Enjoy! https://t.co/x1pzyOICAF
Early diagnosis of arthritis improves outcomes and quality of life in patients with psoriasis. A longitudinal cohort study shows that the development of PsA within clinically meaningful time frames can be predicted with reasonable accuracy for psoriasis patients.
For many rheumatologists around the world, coming to America was a pilgrimage of sorts. A long journey and an expensive exercise but a worthy one – a fundamentally human exchange of ideas, where the person next to you could be from Arkansas, Alberta, or Amsterdam, but equally from Argentina, Algeria, Azerbaijan, or even Australia. So how (dare I say, on earth) do we translate that to our electronic screens?
Global Rheumatology Alliance Panel

Dr. Kathryn Dao interviews Dr. Jinoos Yazdany, Dr. Philip Robinson and Dr. Jean Liew with the Global Rheumatology Alliance.

Abatacept in RA and ILD Patients: Dr Richard Conway

Dr. Richard Conway discusses abstract #0233 presented Friday at the 2020 ACR virtual annual meeting.

I always think of why I attend the ACR: to gain new information and knowledge and bring it back to my clinic for my patients. Here's what I'm looking forward to this year.
Dr. Neal Birnbaum Previews ACR 2020 and Predicts the Future

Past ACR President Dr. Neal Birnbaum discusses the pros and cons of a virtual conference ... and predicts what future meetings may look like.

COVID, Artificial Intelligence and Metabolomics at ACR 2020: Dr. Arthur Kavanaugh

Dr. Arthur Kavanaugh provides an overview of the ACR 2020 meeting, including his review of COVID, machine learning (AI) and metabolomics sessions. 

Dr. Vibeke Strand previews ACR 2020 highlights, including The Great Debate

Dr. Vibeke Strand discusses opening day at ACR 2020, sessions she's looking forward, and provides a sneak peek into The Great Debate. 

Crystal Arthritis and Gout Highlights at ACR: Dr. Nicola Dalbeth

Gout specialist Dr. Nicola Dalbeth from Aukland, New Zealand provides a preview perspective on crystal arthritis and gout studies and sessions at ACR 2020.

From flu shots and face masks to vaccines and searching for the immunological endotype, here are six things rheumatologists need to know about COVID-19.
Pearls for Navigating ACR 2020: Drs. Meral El Ramahi and Kevin Byram

In this video, Dr. El Ramahi talks with Dr. Kevin Byram, on his thoughts about maximizing participation in ACR, vasculitis and other sessions he is interested in attending, and what abstracts he is excited to see presented.

Rheumatology Training and Education: Dr. Janet Pope Interviews Trainees

Dr. Janet Pope meets with several rheumatology trainees to discuss training and education in this COVID-19 era. Interviewees includes Drs. Arpat Gantayet, Gabriel Jeyasingham, Gemma Cramarossa and Melissa Holdren.

RT @drpnash: Association of Hydroxychloroquine Use with Development of Non-Alcoholic Fatty Liver Disease in Rheumatoid A

Peter Nash drpnash

5 years 11 months ago
Association of Hydroxychloroquine Use with Development of Non-Alcoholic Fatty Liver Disease in Rheumatoid Arthritis https://t.co/3PrWlIGnB8 #RA #HCO #NASH - HCO decreases fatty liver
×